Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.55563/clinexprheumatol/2v6v5j http://scihub22266oqcxt.onion/10.55563/clinexprheumatol/2v6v5j 33938790!ä!33938790 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Exp+Rheumatol 2021 ; 39 Suppl 129 (2): 149-154 Nephropedia Template TP {{tp|p=33938790|t=2021. Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis |pdf=|usr=}}{{33938790}} gab.com Text Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis JO: Clin Exp Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=33938790 #FOAvip People with cryoglobulinaemic vasculitis (CV) have an increased risk of infections, attributed to different causes: impairment of the immune system due to the disease itself, comorbidities, and immunosuppressive therapy. Therefore, these patients may be at high risk for a more severe course of COVID-19, including hospitalisation and death. Concerns about efficacy, immunogenicity and safety of vaccines, as well as doubts, not yet fully clarified in patients with systemic autoimmune diseases, represent other important factors for a low vaccination rate in people with (CV). Indeed, providing an expert position on the issues related to SARS-CoV-2 vaccination in patients suffering from CV is of critical relevance in order to help both patients and clinicians who are treating them in making the best choice in each case. A multidisciplinary task force of the Italian Group for the Study of Cryoglobulinaemia (GISC) was convened, and through a Delphi technique produced provisional recommendations regarding SARS-CoV-2 vaccination in cryoglobulinaemic patients. Twit Text FOAVip Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis ????Clin Exp Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=33938790 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33938790 #FOAvip English Wikipedia <ref>{{Cite pmid|33938790}}</ref> Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis #MMPMID33938790 Scarpato S; Sebastiani M; Quartuccio L; Marson P; Fraticelli P; Castelnovo L; Visentini M; Candela M; Mazzaro C; Saccardo F; Pioltelli P; Casato M; Filippini D; Monti G; Galli M Clin Exp Rheumatol 2021[Mar]; 39 Suppl 129 (2): 149-154 PMID33938790show ga People with cryoglobulinaemic vasculitis (CV) have an increased risk of infections, attributed to different causes: impairment of the immune system due to the disease itself, comorbidities, and immunosuppressive therapy. Therefore, these patients may be at high risk for a more severe course of COVID-19, including hospitalisation and death. Concerns about efficacy, immunogenicity and safety of vaccines, as well as doubts, not yet fully clarified in patients with systemic autoimmune diseases, represent other important factors for a low vaccination rate in people with (CV). Indeed, providing an expert position on the issues related to SARS-CoV-2 vaccination in patients suffering from CV is of critical relevance in order to help both patients and clinicians who are treating them in making the best choice in each case. A multidisciplinary task force of the Italian Group for the Study of Cryoglobulinaemia (GISC) was convened, and through a Delphi technique produced provisional recommendations regarding SARS-CoV-2 vaccination in cryoglobulinaemic patients. |*COVID-19[MESH] |*Cryoglobulinemia[MESH] |*Vasculitis[MESH] |COVID-19 Vaccines[MESH] |Humans[MESH] |Italy[MESH] |SARS-CoV-2[MESH]Provisional recommendations for SARS-CoV-2 vaccination in patients wit(epmc).pdf DeepDyve Pubget Overpricing